Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edgewise Therapeutics (EWTX) Capital Expenditures (2020 - 2026)

Edgewise Therapeutics has reported Capital Expenditures over the past 7 years, most recently at $41000.0 for Q1 2026.

  • Quarterly results put Capital Expenditures at $41000.0 for Q1 2026, down 6.82% from a year ago — trailing twelve months through Mar 2026 was $253000.0 (up 551.79% YoY), and the annual figure for FY2025 was $256000.0, up 481.82%.
  • Capital Expenditures reached $41000.0 in Q1 2026 per EWTX's latest filing, down from $209000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $4.4 million in Q1 2023 and bottomed at -$160000.0 in Q4 2024.
  • Median Capital Expenditures over the past 5 years was $142000.0 (2022), compared with a mean of $505647.1.
  • The largest annual shift saw Capital Expenditures soared 1313.59% in 2023 before it crashed 199.38% in 2024.
  • Over 5 years, Capital Expenditures stood at -$70000.0 in 2022, then skyrocketed by 330.0% to $161000.0 in 2023, then plummeted by 199.38% to -$160000.0 in 2024, then skyrocketed by 230.62% to $209000.0 in 2025, then tumbled by 80.38% to $41000.0 in 2026.
  • Business Quant data shows Capital Expenditures for EWTX at $41000.0 in Q1 2026, $209000.0 in Q4 2025, and -$47000.0 in Q3 2025.